MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited)

MHRA Class 3 Medicines Recall: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml (Aspire Pharma Limited)

Drug Alert Number: EL(26)A/47

Date issued: 4 November 2026

Aspire Pharma Ltd is recalling specific batches of Tropicamide 1% Eye Drops, solution in single dose containers 0.5ml x 20, due to them being labelled with the incorrect expiry date. The correct expiry date for these batches should be 31/10/2026.

Marketing Authorisation Holder: Aspire Pharma Ltd

Medicine Details

Product name: Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml

PL: 35533/0198

Active ingredient: tropicamide

SNOMED code: 45542111000001107

GTIN: 5060209733661

Affected Lot Batch Numbers

Batch number Expiry date Pack size First distributed
E941A 30/04/2027* 20 29/10/2025
E941B 30/04/2027* 20 04/02/2026
E941C 30/04/2027* 20 20/02/2026

*Incorrect expiry date printed on packs

Background

Aspire Pharma Ltd is recalling the above specific batches of Tropicamide 1% Eye Drops, solution in single dose containers 0.5ml x 20, due to them being labelled with the incorrect expiry date. The correct expiry date for these batches should be 31/10/2026.

Advice for Healthcare Professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

View the full alert here.

Advice for Patients

No further action is required by patients. This recall is being undertaken as a precautionary measure at the Pharmacy and Wholesaler level.

Patients in possession of these batches should continue to use the eye drops and contact their prescriber to obtain a replacement prescription. No reports of adverse incidents due to this defect have been received to date.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Additional information

For all medical information enquiries and information on this product, please email medinfo@aspirepharma.com, or telephone 01730 231148.

For stock control enquiries please email customerservices@aspirepharma.com, or telephone 01730 231148.

Click Here